Trials / Completed
CompletedNCT00925678
DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season
A Double-blind, Placebo-controlled, Randomised Study to Investigate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of DSP-3025 Administered Intranasally to Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Sumitomo Pharma Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
Investigate safety/tolerability after a single dose intranasal administration of DSP-3025 comparator placebo to healthy male volunteers and seasonal allergic rhinitis male patients out of season.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DSP-3025 | |
| DRUG | Placebo |
Timeline
- Start date
- 2009-06-01
- First posted
- 2009-06-22
- Last updated
- 2022-04-12
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00925678. Inclusion in this directory is not an endorsement.